Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: KLOXXADO
Dosage Form; Route of Administration: SPRAY; NASAL
Strength: 8MG/SPRAY
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N212045
Product Number: 001
Approval Date: Apr 29, 2021
Applicant Holder Full Name: HIKMA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
